Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Acotec Scientific Holdings Limited ( (HK:6669) ) just unveiled an announcement.
Acotec Scientific Holdings Limited announced that it has received registration approval from the PRC National Medical Products Administration for its new product, the Microcatheter V-otter. This microcatheter is designed for Transarterial Chemoembolization (TACE) procedures and features a large-lumen design to prevent catheter occlusion, offering various tip configurations for precise access to target vessels. The company plans to market this product in the PRC market, although there is no guarantee of successful commercialization.
The most recent analyst rating on (HK:6669) stock is a Hold with a HK$13.50 price target. To see the full list of analyst forecasts on Acotec Scientific Holdings Limited stock, see the HK:6669 Stock Forecast page.
More about Acotec Scientific Holdings Limited
Acotec Scientific Holdings Limited is a company incorporated in the Cayman Islands, focusing on the medical industry. It specializes in developing products for percutaneous interventional procedures, particularly in peripheral and coronary vasculature.
Average Trading Volume: 608,038
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.82B
See more insights into 6669 stock on TipRanks’ Stock Analysis page.